Log In
BCIQ
Print this Print this
 

RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)

BCIQ
Print ChartPrint this
1 0 1 0 1 0 2 1
Phases of DevelopmentPreclinicalPhase I
Autoimmune

2

1

Endocrine / Metabolic

1

0

Inflammation

1

0

Pulmonary

1

0




 Products Targeting RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

$135.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today